Capital International Investors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19B | Buy |
|
|||||
|
2025
Q1 | $2.3B | Sell |
|
|||||
|
2024
Q4 | $2.46B | Buy |
|
|||||
|
2024
Q3 | $2.87B | Buy |
|
|||||
|
2024
Q2 | $2.86B | Buy |
|
|||||
|
2024
Q1 | $2.34B | Sell |
|
|||||
|
2023
Q4 | $2.34B | Buy |
|
|||||
|
2023
Q3 | $2.34B | Sell |
|
|||||
|
2023
Q2 | $2.74B | Buy |
|
|||||
|
2023
Q1 | $2.65B | Sell |
|
|||||
|
2022
Q4 | $2.77B | Buy |
|
|||||
|
2022
Q3 | $2.21B | Buy |
|
|||||
|
2022
Q2 | $2.61B | Buy |
|
|||||
|
2022
Q1 | $2.46B | Buy |
|
|||||
|
2021
Q4 | $2.06B | Buy |
|
|||||
|
2021
Q3 | $2.09B | Buy |
|
|||||
|
2021
Q2 | $1.92B | Buy |
|
|||||
|
2021
Q1 | $1.5B | Buy |
|
|||||
|
2020
Q4 | $1.3B | Sell |
|
|||||
|
2020
Q3 | $1.6B | Sell |
|
|||||
|
2020
Q2 | $1.58B | Buy |
|
|||||
|
2020
Q1 | $1.27B | Buy |
|
|||||
|
2019
Q4 | $1.14B | Buy |
|
|||||
|
2019
Q3 | $741M | Buy |
|
|||||
|
2019
Q2 | $686M | Buy |
|
|||||
|
2019
Q1 | $455M | Buy |
|
|||||
|
2018
Q4 | $427M | Buy |
|
|||||
|
2018
Q3 | $386M | Buy |
|
|||||
|
2018
Q2 | $331M | Buy |
|
|||||
|
2018
Q1 | $330M | Sell |
|
|||||
|
2017
Q4 | $346M | Sell |
|
|||||
|
2017
Q3 | $338M | Sell |
|
|||||
|
2017
Q2 | $565M | Sell |
|
|||||
|
2017
Q1 | $576M | Buy |
|
|||||
|
2016
Q4 | $491M | Sell |
|
|||||
|
2016
Q3 | $677M | Buy |
|
|||||
|
2016
Q2 | $618M | Buy |
|
|||||
|
2016
Q1 | $472M | Buy |
|
|||||
|
2015
Q4 | $552M | Buy |
|
|||||
|
2015
Q3 | $517M | Buy |
|
|||||
|
2015
Q2 | $412M | Buy |
|
|||||
|
2015
Q1 | $276M | Buy |
|
|||||
|
2014
Q4 | $139M | Buy |
|
|||||
|
2014
Q3 | $112M | Buy |
|
|||||
|
2014
Q2 | $116M | Buy |
|
|||||
|
2014
Q1 | $101M | Hold |
|
|||||
|
2013
Q4 | $92.5M | Buy |
|